Zynerba Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
154.70
9,330.70
41,513.10
30,985.80
62,530.40
59,763.80
Total Accounts Receivable
34.50
-
356.70
3,613.90
3,983.60
3,444.60
Other Current Assets
500.10
1,183.90
1,545.90
1,811.00
1,473.10
3,491.30
Total Current Assets
689.30
10,514.60
43,415.70
36,410.70
67,987.10
66,699.70
Net Property, Plant & Equipment
47.80
19.60
227.60
143.40
164.50
372
Other Assets
1,123.80
1,082.40
0.20
0.20
902.60
255.80
Total Assets
1,860.80
11,616.70
43,643.50
36,554.30
69,054.30
67,327.40
ST Debt & Current Portion LT Debt
125.00
-
-
-
-
Accounts Payable
308.30
313.90
823.40
1,848.10
3,355.30
Other Current Liabilities
1,129.10
2,831.60
3,114.20
5,118.90
4,087.50
Total Current Liabilities
1,562.40
3,145.50
3,937.60
6,967.00
7,442.70
Long-Term Debt
375.00
-
-
-
-
Other Liabilities
-
-
-
-
662.00
Total Liabilities
1,937.40
3,145.50
3,937.60
6,967.00
8,104.70
Common Equity (Total)
4,359.10
8,051.70
39,705.90
29,587.30
60,949.60
Total Shareholders' Equity
4,359.10
8,051.70
39,705.90
29,587.30
60,949.60
Total Equity
4,359.10
8,051.70
39,705.90
29,587.30
60,949.60
Liabilities & Shareholders' Equity
1,860.80
11,616.70
43,643.50
36,554.30
69,054.30
Non-Equity Reserves
4,282.50
16,522.80
-
-
-
About Zynerba Pharmaceuticals
View Profile
